Alexion Pharmaceuticals I... (ALXN)

AI Score

Unlock

182.50

0.00 (0.00%)

At close: Jan 01, 1970, 12:00 AM

Alexion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	6.26B	6.07B	5.86B	5.54B	5.3B	4.99B	4.74B	4.5B	4.34B	4.13B	3.91B	3.75B	3.61B	3.55B	3.47B	3.41B	3.25B	3.08B	2.95B	2.82B	2.7B
Cost of Revenue	567.2M	553.5M	515.6M	466.1M	420.4M	394.5M	377M	372.4M	368.5M	374.3M	421.7M	488.1M	476.8M	454.2M	377.29M	291.39M	268.01M	258M	248.33M	231.3M	222.68M
Gross Profit	5.69B	5.52B	5.35B	5.07B	4.88B	4.6B	4.36B	4.13B	3.97B	3.76B	3.49B	3.26B	3.14B	3.1B	3.09B	3.12B	2.98B	2.83B	2.71B	2.59B	2.48B
Operating Income	2.76B	2.86B	2.76B	2.55B	2.38B	2.14B	2.02B	1.88B	1.77B	1.59B	1.29B	1.02B	889.6M	804M	898.41M	962.57M	879.89M	793M	705.24M	682.87M	712.68M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	508M	569M	580.4M	449M	2.3B	2.18B	1.54B	1.35B	432.4M	242.2M	364.9M	80.8M	705.4M	547.8M	562.32M	662.44M	626.4M	576M	546.22M	527.47M	534.79M
Net Income	681.8M	603.4M	956.6M	846.1M	2.37B	2.4B	1.47B	1.33B	416.4M	77.6M	152.9M	-100M	522.4M	443.3M	505.44M	521.77M	471.72M	393.88M	368.05M	89.96M	145.23M
Selling & General & Admin	1.42B	1.4B	1.34B	1.3B	1.3B	1.26B	1.2B	1.16B	1.14B	1.11B	1.09B	1.1B	1.09B	1.09B	1.06B	1.02B	983.44M	954M	936.07M	918.46M	908.04M
Research & Development	1.09B	1B	977.5M	924.5M	891M	886M	822M	763.9M	749.7M	730.4M	790.2M	810.4M	836M	878.4M	818.71M	819.4M	799.71M	757M	742.32M	712.3M	664.68M
Other Expenses	233.2M	253.7M	274.4M	296.9M	303.3M	309.6M	315.7M	320.1M	320.1M	320.1M	320.2M	320.2M	320.1M	320.1M	319.81M	321.85M	321.91M	322M	322.16M	276.73M	196.68M
Operating Expenses	2.75B	2.66B	2.59B	2.52B	2.49B	2.46B	2.34B	2.24B	2.21B	2.16B	2.2B	2.23B	2.25B	2.29B	2.2B	2.16B	2.11B	2.03B	2B	1.91B	1.77B
Interest Expense	106M	104.7M	98.7M	89M	83.7M	77.8M	80.6M	87.3M	94M	98.2M	99.1M	99.5M	98.5M	98.4M	97.51M	97.32M	97.11M	97M	95.64M	90.81M	70.98M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.31B	3.21B	3.1B	2.99B	2.91B	2.85B	2.71B	2.61B	2.57B	2.54B	2.62B	2.72B	2.72B	2.75B	2.57B	2.45B	2.37B	2.29B	2.25B	2.14B	1.99B
Income Tax Expense	-27M	-34.4M	-376.2M	-397.1M	-73.4M	-225.5M	73.6M	16.9M	16M	164.6M	212M	180.8M	183M	104.5M	56.89M	140.66M	154.69M	182.12M	178.17M	437.51M	389.57M
Shares Outstanding (Basic)	220.1M	219.1M	219.1M	220.6M	221.6M	221.3M	223.3M	224.2M	223.8M	223.2M	222.9M	222.6M	222.1M	223.3M	223M	224M	224M	225M	224.18M	224.09M	225.06M
Shares Outstanding (Diluted)	222.6M	219.1M	220.6M	220.6M	222.6M	222.5M	224.5M	225.6M	225.5M	223.2M	224.6M	222.6M	223.7M	225M	225M	225M	226M	226M	226.09M	225.76M	226.87M
EPS (Basic)	3.14	2.77	4.34	3.79	10.68	10.79	6.57	5.96	1.86	0.35	0.69	-0.44	2.35	1.99	2.26	2.33	2.10	1.75	1.64	0.41	0.74
EPS (Diluted)	3.09	2.73	4.28	3.74	10.62	10.73	6.53	5.92	1.83	0.33	0.66	-0.46	2.32	1.96	2.24	2.31	2.09	1.75	1.63	0.40	0.72
EBITDA	1.08B	1B	1.02B	900.2M	2.75B	2.63B	2.01B	1.83B	927.4M	745.7M	956.6M	678M	1.3B	1.14B	1.07B	1.16B	1.12B	1.07B	1.03B	956.33M	858.6M
EBIT	614M	673.7M	679.1M	538M	2.38B	2.26B	1.62B	1.44B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	315.7M	329.4M	344.9M	362.2M	368.9M	376.8M	384.6M	397M	401M	405.3M	492.6M	497.7M	499.2M	496.7M	411.74M	402.42M	398.22M	396M	389.02M	338.06M	252.83M